Sleeper, Olivia
Fortino, Justin
Cho, Nam Woo
Daud, Adil I.
Tsai, Katy K.
Lee, James C.
Alvarado, Michael
Maker, Ajay V.
Liu, Lauren
Kim, Christine
Chan, Jason W.
Article History
Received: 28 August 2025
Accepted: 24 March 2026
First Online: 2 April 2026
Declarations
:
: All procedures performed in studies involving human participants were in accordance with the Helsinki Declaration and were approved by the University of California, San Francisco Institutional Review Board with a waiver of informed consent (22-37690).
: Not applicable.
: Dr Tsai reported receiving institutional research funding from AstraZeneca, ABM Therapeutics, BioAtla, Oncosec, Pfizer, Replimune, Regeneron, Genentech, and OnKure; and serving on the advisory board for and receiving institutional research funding from BMS outside the submitted work. Dr. Chan reported receiving institutional research funding from Nanobiotix. No other disclosures were reported.